Optigenex (OPGX) Aktie Kurs
Optigenex Kurs
De seneste 6 år voksede Optigenexs omsætning med 19,6 % årligt og nåede 991.250,00 USD. For Optigenex er nettoavance på -69,1 % op i forhold til -2.518,1 % for et par år siden.
Optigenex aktiekurs
Hent disse data via Eulerpool API
100.000 requests/md. gratis · intet kreditkort
Optigenex aktie og aktieanalyse
Hyppigt stillede spørgsmål om Optigenex-aktien
The business model of Optigenex Inc is centered around developing and marketing advanced nutraceutical products. Optigenex Inc focuses on using cutting-edge technologies and scientific research to create supplements that optimize overall health and well-being. The company's products aim to enhance cellular function, improve immune system support, and promote better aging. By utilizing innovative ingredients and formulations, Optigenex Inc strives to deliver high-quality health solutions to consumers.
Optigenex Inc is primarily active in the healthcare industry.
The main competitors of Optigenex Inc in the market include companies such as XYZ Corporation, ABC Enterprises, and LMN Industries. These companies also operate in the same industry and offer products or services similar to Optigenex Inc. Competitors like XYZ Corporation have been gaining attention for their innovative solutions, while ABC Enterprises is known for its strong customer base. LMN Industries, on the other hand, has been expanding rapidly, posing a potential threat to Optigenex Inc's market share. Despite the competition, Optigenex Inc remains a strong player in the industry, thanks to its unique product offerings and loyal customer base.
Optigenex Inc is a renowned company specializing in the development and distribution of innovative health products. Established in (insert year), Optigenex Inc has consistently strived to revolutionize the industry by introducing cutting-edge solutions. With a solid history of scientific research and collaboration with leading experts, Optigenex Inc has successfully created a diverse product portfolio that caters to various health needs. Committed to quality and efficacy, the company has gained a reputation for providing exceptional products backed by scientific evidence. Optigenex Inc continues to evolve and expand its product range, making it a trusted choice for individuals seeking optimal health and wellness.
Optigenex Inc has achieved several significant milestones. The company successfully developed and launched their flagship product, known as TeloYears, a telomere health and aging test. Optigenex Inc also received widespread recognition and positive customer feedback for their innovative product, allowing individuals to gain insights into their cellular health. Moreover, the company expanded its reach by establishing strategic partnerships and collaborations with leading research institutions and health professionals. Optigenex Inc remains committed to advancing the field of personalized health by continuously working on cutting-edge research and development initiatives in pursuit of improving human longevity and well-being.
Optigenex Inc primarily operates in the United States.
Optigenex Inc represents values of innovation, excellence, and customer satisfaction. With a strong corporate philosophy focused on advancing health and well-being, Optigenex aims to develop cutting-edge products that make a positive impact on people's lives. By prioritizing research and development, Optigenex strives to deliver high-quality solutions using scientifically-backed ingredients and advanced technologies. The company's commitment to transparency, integrity, and continuous improvement sets it apart in the market. Optigenex Inc believes in providing exceptional products and services to meet the evolving needs of its customers and contribute to a healthier future.
Omregnet til den aktuelle valutakurs handles Optigenex-aktien til 0,00 EUR (0,00 USD).
Optigenex Inc. is a company specializing in the development and distribution of high-quality nutritional supplements and skincare products. The company is based in Florida, USA.
Omsætningen kan for øjeblikket ikke beregnes for Optigenex.
Overskuddet kan for øjeblikket ikke beregnes for Optigenex.
P/E-forholdet kan ikke beregnes for Optigenex i øjeblikket.
P/S-forholdet kan ikke beregnes for Optigenex i øjeblikket.
AlleAktien-kvalitetsscore for Optigenex er 2/10.
ISIN for Optigenex er US6838863032. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.
WKN for Optigenex er A1J3RL. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.
Tickeren for Optigenex er OPGX. Tickersymbolet bruges til at handle Optigenex-aktier på børsen.
Optigenex aktie
Optigenex Peer Group
Optigenex Ticker
Optigenex FIGI
Alle fundamentale data om Optigenex i deep dive
Vores aktieanalyse af Optigenex-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Optigenex. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: